发明名称 Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
摘要 A method for killing infectious microbial cells by exposing the microbial cells to endogenous antimicrobial compounds. Activation of the antimicrobials is achieved by addition of low permeability, non-ionic osmolytes to lower ionic strength in body fluids where the antimicrobials have been previously suppressed by alteration of ionic transport (increase in salt concentration). The method can be used to treat cystic fibrosis. Cystic fibrosis causes elevated salt concentrations in the airway surface liquid (ASL) occur due to the impaired chloride transport across the epithelia. Xylitol has been found to be an effective low permeability, non-ionic osmolyte for use in the present invention.
申请公布号 US2002022668(A1) 申请公布日期 2002.02.21
申请号 US20010861841 申请日期 2001.05.21
申请人 发明人 WELSH MICHAEL J.;ZABNER JOSEPH
分类号 A61K9/00;A61K31/047;(IPC1-7):A61K31/045 主分类号 A61K9/00
代理机构 代理人
主权项
地址